Business innovation also need practical tools. Thanks to the contributes of speakers from the institutional, health and business world, Innovabiomed will face the perspectives and the problems regarding the development and introduction of new technologies on the market, also dealing with the issues of fiscal and financial incentives up to the news related to cyber security.

     

    The official program includes the following appointments:

     

    January 23 | 3.00 pm – 5.30 pm

    STUDIO MASOTTI BERGER CASSELLA: “Innovation in the biomedical: new tools and tax incentives”
    Speakers:
    Luca Masotti, partner – Masotti Berger Cassella
    Mascia Cassella, partner – Masotti Berger Cassella
    Francesca Masotti, partner – Masotti Berger Cassella
    Matteo Castronovo, associate – Masotti Berger Cassella


    January 24th | 9.30 am – 12.30 pm
    ANTARES VISION: “Innovation and EU funding for the biomedical sector in Horizon 2020”
    Speakers:

    Isella Vicini, Warrant Group – Director of European Funding Division
    Prof. Renata Medaglini, University of Siena
    Prof. Fabio Biscarini, University of Modena and Reggio Emilia
    Lisa Bregoli, Warrant Group – European Funding Division, senior project manager for Life Sciences
    Paolo Neri, Warrant Group – European Funding Division, Liaison Officer
    Paolo Gilberti, Antares Vision S.r.l.
    Enrico Salvarani, Lameplast Group S.p.a.
    Gloria Loschi, Revealth S.r.l.


    January 24th | 3.00 pm – 5.30 pm

    ANTHEA S.P.A: “From cyber risk to privacy protection: new regulatory obligations and risk management opportunities”
    Speakers:
    Ing. Maurizio Squaiella
    , Senior Consultant – Top Management Consulting Srl
    Avv. Riccardo Facchin, Legal Consultant – Top Management Consulting Srl
    Mr. Paolo Marson – Anthea Spa

     

    In addition to these three important seminars at Innovabiomed there will also be a series of workshops organized by companies that make innovation the central point of their activity and who are interested in presenting themselves to the manufacturers of medical devices.